|
TSPAN5 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.974000E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.986990E-01 |
| Normal-vs-Stage2 |
4.526600E-01 |
| Normal-vs-Stage3 |
2.39719355477064E-12 |
| Normal-vs-Stage4 |
8.73259999978337E-07 |
| Stage1-vs-Stage2 |
3.248200E-01 |
| Stage1-vs-Stage3 |
1.210090E-04 |
| Stage1-vs-Stage4 |
8.563800E-03 |
| Stage2-vs-Stage3 |
1.030370E-01 |
| Stage2-vs-Stage4 |
1.344960E-01 |
| Stage3-vs-Stage4 |
2.830200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.900200E-02 |
| Normal-vs-AfricanAmerican |
9.062600E-01 |
| Normal-vs-Asian |
1.696920E-03 |
| Caucasian-vs-AfricanAmerican |
4.642800E-01 |
| Caucasian-vs-Asian |
1.296360E-02 |
| AfricanAmerican-vs-Asian |
7.057500E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.799380E-01 |
| Normal-vs-Female |
6.418700E-03 |
| Male-vs-Female |
3.716800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.109820E-01 |
| Normal-vs-Age(41-60Yrs) |
5.852200E-01 |
| Normal-vs-Age(61-80Yrs) |
2.238200E-03 |
| Normal-vs-Age(81-100Yrs) |
1.78648999999975E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.184800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.628600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.623040E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.339800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.714230E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.017700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.318100E-02 |
| Normal-vs-Grade 2 |
3.380600E-01 |
| Normal-vs-Grade 3 |
1.191110E-04 |
| Normal-vs-Grade 4 |
1.39070000004793E-06 |
| Grade 1-vs-Grade 2 |
4.498400E-01 |
| Grade 1-vs-Grade 3 |
6.086000E-01 |
| Grade 1-vs-Grade 4 |
3.757200E-01 |
| Grade 2-vs-Grade 3 |
1.688550E-01 |
| Grade 2-vs-Grade 4 |
6.001700E-02 |
| Grade 3-vs-Grade 4 |
4.438400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.13319999944994E-08 |
| Normal-vs-ccB subtype |
3.257800E-01 |
| ccA subtype-vs-ccB subtype |
7.364300E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.347800E-01 |
| Normal-vs-N1 |
7.53610000000515E-05 |
| N0-vs-N1 |
8.498200E-03 |
|
|
